Comparison of the role of 18F-fluorodeoxyglucose PET/computed tomography and 68Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma.
Sign Up to like & getrecommendations! Published in 2023 at "Nuclear medicine communications"
DOI: 10.1097/mnm.0000000000001702
Abstract: OBJECTIVE In this study, we aimed to compare the role of 68Ga-labeled FAP inhibitor (68Ga-FAPI)-04 PET/computed tomography (CT) and 18F-fluorodeoxyglucose (18F-FDG) PET/CT in the evaluation of primary tumor and metastases in patients diagnosed with malignant… read more here.
Keywords: 68ga labeled; pet; malignant mesothelioma; fapi pet ... See more keywords